Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 1,400 shares at $125.19 ($176K) on 2019-06-10, disclosed to the SEC on 2019-06-12.
Open-market sale of $176k BLUE by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.19 | 1,200 | $150K | 85.5% |
| 2 | $126.96 | 200 | $25K | 14.5% |
| Total | $125.44 avg | 1,400 | $176K | 100% |
| Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |
| BLUE | SELL | 2019-03-13 | $419K | — | Filing → |